ARCUTIS BIOTHERAPEUTICS INC. - COMMON STOCK
10.40
12-十一月-24 14:51:54
15 分钟延时
股票
-0.45
-4.11%
今日范围
10.38 - 10.74
ISIN
N/A
来源
NASDAQ
-
Arcutis to Host ZORYVE® (Roflumilast) Cream 0.15% FDA Approval Call With KOL
22 7月 2024 08:00:00 条件 Nasdaq GlobeNewswire
-
09 7月 2024 16:53:01 条件 Nasdaq GlobeNewswire
-
Arcutis Provides Update on sNDA for Roflumilast Cream 0.15% for Atopic Dermatitis
09 7月 2024 08:00:00 条件 Nasdaq GlobeNewswire
-
Arcutis Biotherapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
03 7月 2024 16:00:00 条件 Nasdaq GlobeNewswire
-
Arcutis Biotherapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
05 6月 2024 16:00:00 条件 Nasdaq GlobeNewswire
-
Arcutis to Present at the Goldman Sachs 45th Annual Global Healthcare Conference
03 6月 2024 08:00:00 条件 Nasdaq GlobeNewswire
-
Arcutis Announces First Quarter 2024 Financial Results and Provides Business Update
14 5月 2024 16:00:00 条件 Nasdaq GlobeNewswire
-
Arcutis Biotherapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
03 5月 2024 16:00:00 条件 Nasdaq GlobeNewswire
-
Arcutis to Report First Quarter 2024 Financial Results and Host Conference Call on May 14, 2024
29 4月 2024 16:00:00 条件 Nasdaq GlobeNewswire
-
Arcutis Appoints David Topper as Chief Financial Officer
10 4月 2024 08:00:00 条件 Nasdaq GlobeNewswire
-
Arcutis Biotherapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
05 4月 2024 16:00:00 条件 Nasdaq GlobeNewswire
-
Arcutis to Present at the 23rd Annual Needham Virtual Healthcare Conference
28 3月 2024 08:00:00 条件 Nasdaq GlobeNewswire
-
Arcutis Promotes Todd Tucker to Chief Human Resources Officer
11 3月 2024 08:00:00 条件 Nasdaq GlobeNewswire
-
09 3月 2024 16:00:00 条件 Nasdaq GlobeNewswire
-
Arcutis Biotherapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
05 3月 2024 16:00:00 条件 Nasdaq GlobeNewswire
-
04 3月 2024 16:00:00 条件 Nasdaq GlobeNewswire